Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Lung Cancer

Free Subscription Articles published in Cancer Epidemiol Biomarkers Prev Retrieve available abstracts of 50 articles: HTML format

Single Articles

July 2026
1. BALLESTEROS J, Ikenouchi A, Choi SY, Clark A, et al
   Preferences for Blood-Based Versus Traditional Screening Modalities for Lung and Colorectal Cancers: Insights from a Conjoint Analysis Among US Adults.
   Cancer Epidemiol Biomarkers Prev. 2026;35:1197-1207.
   PubMed     Abstract available
   
   
   
2. YAU STY, Hung CT, Leung EYM, Lee A, et al
   Association between Statin Use and the Risk of Colorectal, Liver, and Lung Cancers: A Population-Based Retrospective Cohort Study.
   Cancer Epidemiol Biomarkers Prev. 2026;35:1189-1196.
   PubMed     Abstract available
   
   
   June 2026
3. GOLDWASSER DL
   How Wide is the Screening Window for Aggressive Non-Small Cell Lung Cancers? The Cure Threshold Metric and its Implications for Lung Cancer Screening Guidelines.
   Cancer Epidemiol Biomarkers Prev. 2026.
   PubMed     Abstract available
   
   
   
4. GORBATOV SD, Bittoni MA, Wu AH, Harper A, et al
   Dietary and Lifestyle Patterns Among Young Patients with Lung Cancer: Analysis of Mutation-Specific Phenotypes.
   Cancer Epidemiol Biomarkers Prev. 2026 Jun 3. doi: 10.1158/1055-9965.EPI-26-0057
   PubMed     Abstract available
   
   
   
5. MCGANN KC, Woodhouse P, Chen H, Kammer MN, et al
   Leveraging Commercially Available Protein Assays as Biomarkers for Lung Cancer.
   Cancer Epidemiol Biomarkers Prev. 2026.
   PubMed     Abstract available
   
   
   May 2026
6. MAO J, Leng L, Zhu T, Wang J, et al
   The association and risk prediction of the ubiquitination pathway genetic variants and lung cancer incidence: A nested case-control study.
   Cancer Epidemiol Biomarkers Prev. 2026.
   PubMed     Abstract available
   
   
   
7. BLECHTER B, Shu XO, Hu W, Francis ER, et al
   Mitochondrial DNA breaks and copy number and the risk of lung cancer in the Shanghai Women's Health Study.
   Cancer Epidemiol Biomarkers Prev. 2026.
   PubMed     Abstract available
   
   
   
8. NAGHASH M, Shaner RL, Poustchi H, Roshandel G, et al
   ?Biomarkers of opioids, volatile organic compounds, and polycyclic aromatic hydrocarbons and lung cancer incidence among opium users.
   Cancer Epidemiol Biomarkers Prev. 2026.
   PubMed     Abstract available
   
   
   April 2026
9. JI J, Xue R, Zhang X, Yang M, et al
   Early Lung Cancer Detection Using Nucleotide Transition Probabilities in Plasma Cell-Free DNA.
   Cancer Epidemiol Biomarkers Prev. 2026 Apr 3. doi: 10.1158/1055-9965.EPI-25-2034
   PubMed     Abstract available
   
   
   March 2026
10. COOMBS LA, Zhou X, Reeder-Hayes KE, Diaz F, et al
    Exploring clinical pathways to a metastatic lung cancer diagnosis: A latent class analysis using North Carolina multi-payer claims data.
    Cancer Epidemiol Biomarkers Prev. 2026.
    PubMed     Abstract available
    
    
    December 2025
11. JIN J, Rahmatallah Y, Gomez-Acevedo H, Park YM, et al
    A Tracts of Homozygosity Approach Identifies Methylation-Regulated CSMD1 Expression Targets in Non-Small Cell Lung Cancers Related to Smoking Behavior.
    Cancer Epidemiol Biomarkers Prev. 2025;34:2247-2258.
    PubMed     Abstract available
    
    
    November 2025
12. HENDERSON LM, Lund JL, Durham DD, Baggett CD, et al
    Burden and impact of frailty and comorbidity in individuals screened for lung cancer.
    Cancer Epidemiol Biomarkers Prev. 2025.
    PubMed     Abstract available
    
    
    
13. DENNISON JB, Gendarme S, Kettner NM, Godoy MCB, et al
    The LEAP Study: A Multicenter Biospecimen and Imaging Resource for Lung Cancer Screening.
    Cancer Epidemiol Biomarkers Prev. 2025 Nov 5. doi: 10.1158/1055-9965.EPI-25-1022
    PubMed     Abstract available
    
    
    
14. NASH SH, Loeffler BT, Verhage E, Sorensen J, et al
    Comorbidities among American Indian and Alaska Native People with Cancer: A Surveillance, Epidemiology, and End Results-Medicare Study.
    Cancer Epidemiol Biomarkers Prev. 2025;34:1914-1923.
    PubMed     Abstract available
    
    
    October 2025
15. CUI L, Lee J, Miller J, Tang M, et al
    Design and creation of a racially diverse lung cancer registry with detailed genomic and environmental annotation.
    Cancer Epidemiol Biomarkers Prev. 2025.
    PubMed     Abstract available
    
    
    
16. HOLOWATYJ AN, Liu L, Munro HM, Perkins-Smith JJ, et al
    Income, Race, and Survival among Low-Income Black and White Americans with Lung, Breast, Prostate, or Colorectal Cancer.
    Cancer Epidemiol Biomarkers Prev. 2025;34:1749-1758.
    PubMed     Abstract available
    
    
    August 2025
17. TAO MH, Wu T, Gordon SC, Zhou Y, et al
    Antiviral treatment Reduces Risk of Development of Lung Cancer and non-Hodgkin Lymphoma in Patients with Chronic Hepatitis C.
    Cancer Epidemiol Biomarkers Prev. 2025.
    PubMed     Abstract available
    
    
    
18. PESTARINO L, Fortner RT, Nost TH, Fotopoulos I, et al
    Recommendations for validating omics prediction models: Insights from a lung cancer RNA biomarker study.
    Cancer Epidemiol Biomarkers Prev. 2025.
    PubMed     Abstract available
    
    
    
19. XU T, Dillon JS, Quelle DE, Nash SH, et al
    Risk Factors Associated with Gastroenteropancreatic and Lung Neuroendocrine Tumors: A Nested Case-Control Study from the All of Us Research Program.
    Cancer Epidemiol Biomarkers Prev. 2025;34:1395-1404.
    PubMed     Abstract available
    
    
    July 2025
20. DRESSLER EV, Weaver KE, Sutfin EL, Bellinger C, et al
    Predictors of cessation readiness among cigarette smokers presenting for low-dose computed tomography lung cancer screening in community settings (WF-20817CD).
    Cancer Epidemiol Biomarkers Prev. 2025.
    PubMed     Abstract available
    
    
    
21. SIVAGNANALINGAM U, Demanelis K, Wang R, Yuan JM, et al
    Prospective examination of cellular and soluble mediators of immune dysregulation and their association with lung cancer risk.
    Cancer Epidemiol Biomarkers Prev. 2025.
    PubMed     Abstract available
    
    
    June 2025
22. BERKMAN AM, Tran M, Thompson LK, Lerman C, et al
    SECONDARY LUNG CANCER AMONG SURVIVORS OF ADOLESCENT AND YOUNG ADULT CANCER: A POPULATION-BASED STUDY.
    Cancer Epidemiol Biomarkers Prev. 2025.
    PubMed     Abstract available
    
    
    
23. FENLON J, Van Bibber N, Mahlow J, Yamoah K, et al
    Human Immunodeficiency Virus-Associated Differences in the Tumor Immune Microenvironment of Lung, Breast, and Prostate Cancers.
    Cancer Epidemiol Biomarkers Prev. 2025;34:860-867.
    PubMed     Abstract available
    
    
    April 2025
24. DAVIES MPA, Field JK, Gatto F
    External validation of plasma glycosaminoglycans as biomarkers to improve lung cancer risk stratification.
    Cancer Epidemiol Biomarkers Prev. 2025.
    PubMed     Abstract available
    
    
    March 2025
25. WOODHOUSE P, Jackson L, Kammer MN, Godfrey CM, et al
    Optimizing Biomarker Models for Biologically Heterogeneous Cancers: A Nested Model Approach for Lung Cancer.
    Cancer Epidemiol Biomarkers Prev. 2025.
    PubMed     Abstract available
    
    
    January 2025
26. MAKI KG, Tan NQP, Volk RJ, Toumazis I, et al
    Examining Lung Cancer Screening Uptake in the United States: Recent Research and Limitations of Public-Use Data.
    Cancer Epidemiol Biomarkers Prev. 2025;34:9-11.
    PubMed     Abstract available
    
    
    
27. HAMAD W, Grigore B, Walford H, Peters J, et al
    Biomarkers Suitable for Early Detection of Intrathoracic Cancers in Primary Care: A Systematic Review.
    Cancer Epidemiol Biomarkers Prev. 2025;34:19-34.
    PubMed     Abstract available
    
    
    December 2024
28. LI J, Cao X, Zhang L, Liu A, et al
    Anti-FDX1 Autoantibody as a Potential Biomarker for Non-Small Cell Lung Cancer Detection.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available
    
    
    November 2024
29. TESEMA GA, Tessema ZT, Heritier S, Stirling RG, et al
    Timeliness of lung cancer care and area-level determinants in Victoria: A Bayesian spatio-temporal analysis.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available
    
    
    
30. TSAY JJ, Darawshy F, Wang C, Kwok B, et al
    Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma.
    Cancer Epidemiol Biomarkers Prev. 2024;33:1433-1444.
    PubMed     Abstract available
    
    
    September 2024
31. GUDINA AT, Kamen CS, Hirko KA, Adler DH, et al
    Lung Cancer Screening Uptake Under the Revised United States Preventive Service Task Force Guideline: Assessing Disparities.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available
    
    
    August 2024
32. MULVANEY R, Pan Y, Zhao N, Teles F, et al
    Blood Leukocyte DNA Methylation Markers of Periodontal Disease and Risk of Lung Cancer in a Case-Control Study Nested in the CLUE II Cohort.
    Cancer Epidemiol Biomarkers Prev. 2024 Aug 2. doi: 10.1158/1055-9965.EPI-24-0279
    PubMed     Abstract available
    
    
    July 2024
33. TRENDOWSKI MR, Watza D, Lusk CM, Lonardo F, et al
    Evaluation of the Immune Response within the Tumor Microenvironment in African American and non-Hispanic White Non-Small Cell Lung Cancer Patients.
    Cancer Epidemiol Biomarkers Prev. 2024 Jul 2. doi: 10.1158/1055-9965.EPI-24-0333
    PubMed     Abstract available
    
    
    June 2024
34. SMELTZER MP, Akinbobola OA, Ray MA, Fehnel C, et al
    Prevalence of Epidermal Growth Factor Receptor and Programmed Death-Ligand 1 testing in a population-based lung cancer surgical resection cohort from 2018-2022.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available
    
    
    
35. BEKELE BB, Lian M, Shrestha P, Nabi O, et al
    Racialized economic segregation and treatment and outcomes of small-cell lung cancer.
    Cancer Epidemiol Biomarkers Prev. 2024 Jun 5. doi: 10.1158/1055-9965.EPI-24-0237
    PubMed     Abstract available
    
    
    
36. PELLINI B, Chaudhuri AA
    Racial Disparities in Early-Stage NSCLC Treatment: A Call for Action.
    Cancer Epidemiol Biomarkers Prev. 2024;33:769-770.
    PubMed     Abstract available
    
    
    
37. THOMAS AL, Rhee J, Fisher JA, Horner MJ, et al
    Fine Particulate Matter, Noise Pollution, and Greenspace and Prostate Cancer Risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Cohort.
    Cancer Epidemiol Biomarkers Prev. 2024;33:857-860.
    PubMed     Abstract available
    
    
    May 2024
38. MURPHY SE, Guillermo C, Thomson NM, Carmella SG, et al
    Association of urinary biomarkers of tobacco exposure with lung cancer risk in African American and White cigarette smokers in the Southern Community Cohort Study.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available
    
    
    April 2024
39. WANG J, Wang Q, Shi Z, Yan X, et al
    Serum lipid levels, genetic risk, and lung cancer incidence: A large prospective cohort study.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available
    
    
    
40. ALLAIRE BT, Horvath ML, Lines LM, Davidoff AJ, et al
    Do Contemporary Cancer Survivors Experience Better Quality of Life? Evaluating a Decade of SEER Medicare Health Outcomes Survey Data.
    Cancer Epidemiol Biomarkers Prev. 2024;33:593-599.
    PubMed     Abstract available
    
    
    February 2024
41. BOOKSTEIN A, Po J, Tseng C, Larson TV, et al
    Association between Airport Ultrafine Particles and Lung Cancer Risk: The Multiethnic Cohort Study.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available
    
    
    
42. PELLAND-ST-PIERRE L, Pham MC, Nguyen AQH, Pasquet R, et al
    The Influence of Smoking and Occupational Risk Factors on DNA Methylation in the AHRR and F2RL3 Genes.
    Cancer Epidemiol Biomarkers Prev. 2024;33:224-233.
    PubMed     Abstract available
    
    
    
43. DEVASIA TP, Howlader N, Dewar RA, Stevens JL, et al
    Increase in the Life Expectancy of Patients with Cancer in the United States.
    Cancer Epidemiol Biomarkers Prev. 2024;33:196-205.
    PubMed     Abstract available
    
    
    January 2024
44. YOON HS, Wu J, Shidal C, Sun Y, et al
    Associations between Plasma Tocopherols and Lung Cancer Risk: Results from the Southern Community Cohort Study.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available
    
    
    
45. LIU Q, Medina HN, Rodriguez E, Jacobs KT, et al
    Trends and Disparities in Curative-Intent Treatment for Early-Stage Non-Small Cell Lung Cancer: A Population-Based Analysis of Surgery and SBRT.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available
    
    
    
46. DUNCAN MS, Diaz-Zabala H, Jaworski J, Tindle HA, et al
    INTERACTION BETWEEN CONTINUOUS PACK-YEARS SMOKED AND POLYGENIC RISK SCORE ON LUNG CANCER RISK: PROSPECTIVE RESULTS FROM THE FRAMINGHAM HEART STUDY.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed     Abstract available
    
    
    
47. GRABSKI IN, Heymach JV, Kehl KL, Kopetz S, et al
    Effects of KRAS Genetic Interactions on Outcomes in Cancers of the Lung, Pancreas, and Colorectum.
    Cancer Epidemiol Biomarkers Prev. 2024;33:158-169.
    PubMed     Abstract available
    
    
    
48. LI Y, Xiao X, Li J, Han Y, et al
    Lung cancer in ever- and never-smokers: findings from multi-population GWAS studies.
    Cancer Epidemiol Biomarkers Prev. 2024 Jan 5. doi: 10.1158/1055-9965.EPI-23-0613
    PubMed     Abstract available
    
    
    November 2023
49. YANG Z, He H, He G, Zeng C, et al
    Investigating Causal Effects of Hematological Traits on Lung Cancer: A Mendelian Randomization Study.
    Cancer Epidemiol Biomarkers Prev. 2023 Nov 1. doi: 10.1158/1055-9965.EPI-23-0725
    PubMed     Abstract available
    
    
    September 2023
50. WONG JY, Shu XO, Hu W, Blechter B, et al
    Associations between longer leukocyte telomere length and increased lung cancer risk among never smokers in urban China.
    Cancer Epidemiol Biomarkers Prev. 2023.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum